Investor profile
Sabadell Asabys has backed 5 European tech companies across 5 funding rounds between 2022 and 2023, joining rounds totalling €65M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Agomab Therapeutics | Belgium | 1 | €41M |
| Cara | Germany | 1 | €7.0M |
| Amelia Virtual Care | Spain | 1 | €7.0M |
| Cara Care | Germany | 1 | €6.6M |
| Deepull | Spain |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Agomab Therapeutics | Series B | €41M | 2022-07 |
| Cara | Other | €7.0M | 2022-06 |
| Amelia Virtual Care | Other | €7.0M | 2022-06 |
| Cara Care |
| 1 |
| €4.0M |
| Other |
| €6.6M |
| 2022-06 |
| Deepull | Other | €4.0M | 2023-03 |
